Debra K Stanley, LCSW | |
725 N 12th Ave Bldg B, Arcadia, FL 34266-8752 | |
(634) 941-2428 | |
(863) 491-0466 |
Full Name | Debra K Stanley |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 725 N 12th Ave Bldg B, Arcadia, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700668233 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | SW10948 (Florida) | Secondary |
101YM0800X | Counselor - Mental Health | SW10948 (Florida) | Primary |
Entity Name | Balanced Wellbeing Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336513639 PECOS PAC ID: 5193021848 Enrollment ID: O20160307002587 |
News Archive
The recommendation that fewer men get screened for the disease goes against what many people believe should be appropriate, NPR reports.
Approximately two million adults in the United States meet criteria for pathological gambling, and another four to six million are considered problem gamblers, according to the National Council on Problem Gambling. A study by researchers at Wayne State University reveals that gambling addiction treatment is not one-size-fits-all, but it is difficult to predict which style of treatment is best for the various forms of gambling addiction.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Researchers from The University of Texas M. D. Anderson Cancer Center have developed a new assessment tool to measure the severity of symptoms that can complicate stem cell transplantation. The tool assesses symptoms resulting from chronic graft-versus-host disease (cGVHD), and was presented with supporting research at the 2010 Bone and Marrow Transplant Tandem Meeting.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Debra K Stanley, LCSW 3740 Whiteway Dairy Rd, Fort Pierce, FL 34947-6339 Ph: (954) 993-4635 | Debra K Stanley, LCSW 725 N 12th Ave Bldg B, Arcadia, FL 34266-8752 Ph: (634) 941-2428 |
News Archive
The recommendation that fewer men get screened for the disease goes against what many people believe should be appropriate, NPR reports.
Approximately two million adults in the United States meet criteria for pathological gambling, and another four to six million are considered problem gamblers, according to the National Council on Problem Gambling. A study by researchers at Wayne State University reveals that gambling addiction treatment is not one-size-fits-all, but it is difficult to predict which style of treatment is best for the various forms of gambling addiction.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Researchers from The University of Texas M. D. Anderson Cancer Center have developed a new assessment tool to measure the severity of symptoms that can complicate stem cell transplantation. The tool assesses symptoms resulting from chronic graft-versus-host disease (cGVHD), and was presented with supporting research at the 2010 Bone and Marrow Transplant Tandem Meeting.
› Verified 2 days ago